PHILADELPHIA (October 23, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of André Kydd, MD, PhD, as an Assistant Professor in the Department of Hematology/Oncology. He will see patients at Fox Chase and Temple University Hospital.
Kydd joins Fox Chase from the National Cancer Institute, where he completed a fellowship in hematology and medical oncology. He brings to Fox Chase a distinctive combination of clinical and translational research expertise in genitourinary malignancies, with a particular focus on rare and aggressive cancers of the bladder and urinary tract.
Kydd earned his medical degree and doctorate in cellular and molecular medicine from the Johns Hopkins University School of Medicine and graduated magna cum laude from Harvard College with a bachelor’s degree in biochemical sciences. He previously served as a hospitalist at Boston Medical Center/Boston University School of Medicine and was chief resident during his internal medicine residency at Florida Atlantic University.
At the National Institutes of Health, Kydd was a lead and associate investigator on multiple clinical trials, including the SMART study, a phase 2 trial exploring the use of an antibody-drug conjugate and immunotherapy in rare bladder and urinary tract cancers. His research has been published in the Journal of Clinical Oncology, Current Opinion in Oncology, and Future Oncology, and he has presented at major national and international conferences, including the American Society of Clinical Oncology and the European Society for Medical Oncology.
Kydd has received several prestigious honors and fellowships, including the Bladder Cancer Advocacy Network John Quale Travel Fellowship Award and the Robert A. Winn Excellence in Clinical Trials Career Development Award. His work focuses on novel immunotherapy and targeted approaches in genitourinary tumors, along with patient-centered clinical trial development.
Kydd began his tenure at Fox Chase on September 13.